LMAT LeMaitre Vascular Inc.

LeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020

LeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020

BURLINGTON, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at the Lotte New York Palace Hotel in New York City.

The Company is scheduled to present at 10:00 a.m. EST.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at .

Contact:  
LeMaitre Vascular, Inc.
Sandra Millar
 
 
EN
18/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LeMaitre Vascular Inc.

 PRESS RELEASE

LeMaitre to Participate in Upcoming Investor Conferences

LeMaitre to Participate in Upcoming Investor Conferences BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences. Jefferies London Healthcare Conference 2025 Tuesday, November 18, 2025Waldorf Hilton, LondonDorian LeBlanc, CFO, will present at 8:00 AM GMT Wolfe Research 7th Annual Healthcare Conference Wednesday, November 19, 2025Wolfe NYC Offices, New York, NYDavid Roberts, President, will present at 10:40 AM ET Piper Sandler 37th Annual Healthcare Conference Th...

 PRESS RELEASE

LeMaitre Q3 2025 Financial Results

LeMaitre Q3 2025 Financial Results BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q3 2025 results include a non-recurring benefit from the Employee Retention Tax Credit. Non-GAAP adjusted figures exclude this benefit. A reconciliation of GAAP to non-GAAP results is included. Q3 2025: Sales $61.0mm, +11% (+12% organic)Gross margin 75.3% (+750 bps), adjusted 70.8% (+300 bps)Op. income $2...

 PRESS RELEASE

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November...

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025 BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the live...

 PRESS RELEASE

LeMaitre to Participate at Upcoming Investor Conferences in September

LeMaitre to Participate at Upcoming Investor Conferences in September BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences. 2025 Wells Fargo Healthcare Conference Wednesday, September 3, 2025 Encore Boston Harbor, Everett, MA Dorian LeBlanc, CFO, will present at 1:30 PM ET Cantor Global Healthcare Conference Thursday, September 4, 2025 InterContinental New York Barclay Hotel, New York, NY Dorian LeBlanc, CFO, will present at 10:55 AM ET Morgan Stanley 23rd ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch